Tan et al., 2006 - Google Patents

Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late‐onset Parkinson's disease

Tan et al., 2006

Document ID
11095895217367272426
Author
Tan E
Skipper L
Chua E
Wong M
Pavanni R
Bonnard C
Kolatkar P
Liu J
Publication year
Publication venue
Movement disorders: official journal of the Movement Disorder Society

External Links

Snippet

The pleomorphic pathology of postmortem LRRK2‐positive patients and the frequent association with late‐onset Parkinson's disease (LOPD) symptoms suggest that LRRK2 mutations may play a role in Parkinson's Plus disorders and LOPD. Published studies …
Continue reading at movementdisorders.onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Similar Documents

Publication Publication Date Title
Tan et al. Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late‐onset Parkinson's disease
Raghavan et al. Whole‐exome sequencing in 20,197 persons for rare variants in Alzheimer's disease
Lill et al. The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease
Hakonen et al. Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin
Kumar et al. Genetics of Parkinson disease and other movement disorders
Skipper et al. Linkage disequilibrium and association of MAPT H1 in Parkinson disease
Wang et al. TGM6 identified as a novel causative gene of spinocerebellar ataxias using exome sequencing
Deng et al. Genetics of essential tremor
Krohn et al. Fine‐mapping of SNCA in rapid eye movement sleep behavior disorder and overt Synucleinopathies
Yan et al. Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia
Xiao et al. Novel THAP1 sequence variants in primary dystonia
Gustavsson et al. DNAJC13 genetic variants in parkinsonism
Berg et al. Alpha‐synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients
Dupré et al. Clinical and genetic study of autosomal recessive cerebellar ataxia type 1
Zech et al. DYT16 revisited: exome sequencing identifies PRKRA mutations in a European dystonia family
Sweet et al. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease
Lee et al. PRRT2 mutations in paroxysmal kinesigenic dyskinesia with infantile convulsions in a Taiwanese cohort
Tan et al. CAG repeat expansion in THAP11 is associated with a novel spinocerebellar ataxia
Conidi et al. Homozygous carriers of APP A713T mutation in an autosomal dominant Alzheimer disease family
Li et al. PRRT 2 c. 649dup C Mutation Derived from De Novo in Paroxysmal Kinesigenic Dyskinesia
Dezfouli et al. PANK2 and C19orf12 mutations are common causes of neurodegeneration with brain iron accumulation
Lake et al. Coding and noncoding variation in LRRK2 and Parkinson's disease risk
Hammer et al. Exome sequencing: an efficient diagnostic tool for complex neurodegenerative disorders
Novak et al. An ITPR1 gene deletion causes spinocerebellar ataxia 15/16: a genetic, clinical and radiological description
Nuytemans et al. Absence of C9ORF72 expanded or intermediate repeats in autopsy‐confirmed Parkinson's disease